Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes.

Source:http://linkedlifedata.com/resource/pubmed/id/11058882

Int. J. Cancer 2000 Nov 15 88 4 633-9

Download in:

View as

Triples

General Info

PMID
11058882